Walden Group Healthcare M&A Blog

  • The Walden Group Represented Total Titanium, Inc in Its Sale to a Subsidiary of Bausch + Lomb Corporation

    12/21/2022
    The Walden Group is pleased to announce that it represented Total Titanium, Inc. (TTI) in its sale to a subsidiary of Bausch + Lomb Corporation (NYSE/TSX:BLCO) (“Bausch + Lomb”). TTI was one of the last remaining independently-owned manufacturers of precision ophthalmic instruments based in the United States. Bausch + Lomb is a leading global...
    Read More
  • The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report

    11/8/2022
    The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes:       Market Overview -- What you need to know about MDR and more       Major M&A Deals by Sector       For Ophthalmology, Orthopedic & Spine, and Woundcare - Key Developments and Deals       Key Stats on Top...
    Read More
  • Aspen Surgical Acquires Symmetry Surgical

    10/27/2022
    Aspen Surgical, a producer of disposable surgical products and a portfolio company of Audax Group, has purchased Symmetry Surgical, a maker of electrosurgery products, instruments and minimally invasive surgical devices, from Roundtable Healthcare Partners.  The acquisition diversifies Aspen’s offerings into electrosurgery including bipolar...
    Read More
  • Halma Purchases IZI Medical Products for $153.5m

    10/12/2022
    Halma plc, a $1.7b UK-based provider of safety, environmental and analysis, and medical technology solutions, has purchased IZI Medical Products, a maker of devices used in image-guided surgery, interventional oncology and interventional spine procedures.  IZI’s offerings include an automatic biopsy system and a vertebral compression fracture...
    Read More
  • CVS Acquires Signify Health for $8b

    9/23/2022
    CVS Health Corporation is buying Signify Health, a $773.4m provider of home and virtual healthcare services.  The acquisition adds a mobile network of 10,000 credentialed clinicians offering in-home evaluations of Medicare Advantage and Medicaid plan members.  The deal represents a shift in the drugstore chain’s traditional brick and mortar...
    Read More